Professional Overview

Daphne Karydas is a seasoned executive currently serving as President and CFO at Flare Therapeutics in New York, New York. Her expertise spans financial management, corporate strategy, and investor relations, with a strong focus on the pharmaceutical and healthcare industries.

Experience Summary

Current Role

As President and CFO at Flare Therapeutics, Daphne oversees the company's financial operations, strategic planning, and growth initiatives. Her key responsibilities include financial planning, risk management, and investor relations. Notably, she has been instrumental in driving the company's financial growth and strategic expansion since assuming her current role in October 2021.

Career Progression

Daphne's career trajectory is marked by progressive leadership roles in the pharmaceutical and financial sectors. Prior to joining Flare Therapeutics, she served as CFO at Syndax Pharmaceuticals, where she played a crucial role in the company's financial planning and strategic growth. Her earlier roles include SVP Corporate FP&A and Strategy, as well as SVP Investor Relations and Strategy at Allergan, where she contributed to the company's strategic planning, financial analysis, and investor engagement. Additionally, Daphne held executive positions at J.P. Morgan Asset Management and The Boston Company Asset Management, further solidifying her expertise in financial management and investment analysis.

Areas of Expertise

Daphne's areas of expertise include financial planning and analysis, strategic planning, investor relations, risk management, and leadership development. Her technical competencies encompass financial modeling, data analysis, and market research, with a strong understanding of the pharmaceutical and healthcare industries.

Professional Impact

Throughout her career, Daphne has made significant contributions to the companies she has served. Her leadership and strategic vision have driven business growth, improved financial performance, and fostered strong investor relationships. While specific metrics and achievements are not available, her tenure at notable companies like Allergan, Syndax Pharmaceuticals, and Flare Therapeutics demonstrates her ability to navigate complex business environments and drive results.

Conclusion

Daphne Karydas is a highly accomplished executive with a strong track record of leadership and strategic growth in the pharmaceutical and healthcare industries. Her current role as President and CFO at Flare Therapeutics leverages her expertise in financial management, corporate strategy, and investor relations to drive business expansion and financial performance. With a career marked by progressive leadership roles and significant industry contributions, Daphne is poised to continue making a lasting impact in her current and future endeavors.